CardioKinetix completes enrollment in Chinese trial of first-of-its-kind parachute device for treatment of heart failure

首页> 外文期刊>Asia-Pacific Biotech News >CardioKinetix completes enrollment in Chinese trial of first-of-its-kind parachute device for treatment of heart failure

【24h】

CardioKinetix completes enrollment in Chinese trial of first-of-its-kind parachute device for treatment of heart failure

机译：CardioKinetix完成了首例用于治疗心力衰竭的降落伞装置的中国试验

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, has completed the enrollment in PARACHUTE China, a multi-center trial to evaluate the minimally invasive Parachute~R Ventricular Partitioning Devicefor the treatment of heart failure.

机译：医疗器械公司CardioKinetix Inc.率先开展了基于导管的心力衰竭治疗，现已完成PARACHUTE China的注册，PARACHUTE China是一项多中心试验，旨在评估用于治疗心力衰竭的微创Parachute〜R心室分配装置。

著录项

来源
《Asia-Pacific Biotech News 》 |2015年第2期| 共1页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类分子生物学 ;
关键词

相似文献

外文文献
中文文献
专利

1. CardioKinetix completes enrollment in Chinese trial of first-of-its-kind parachute device for treatment of heart failure [J] . Asia-Pacific Biotech News . 2015 ,第2期

机译：CardioKinetix完成了首例用于治疗心力衰竭的降落伞装置的中国试验
2. Percutaneous ventricular restoration (PVR) therapy using the Parachute device in 100 subjects with ischaemic dilated heart failure: one-year primary endpoint results of PARACHUTE III, a European trial [J] . Thomas Martyn, Nienaber Christoph A., Ince Hueseyin, EuroIntervention: journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology . 2015 ,第6期

机译：使用降落伞装置进行的100例缺血性扩张性心力衰竭患者的经皮心室恢复（PVR）治疗：一项欧洲试验PARACHUTE III的一年主要终点结果
3. The PARACHUTE IV trial design and rationale: Percutaneous ventricular restoration using the parachute device in patients with ischemic heart failure and dilated left ventricles [J] . CostaM.A., PencinaM., NikolicS., The American heart journal . 2013 ,第4期

机译：PARACHUTE IV试验设计和依据：缺血性心力衰竭和左心室扩张的患者使用降落伞装置进行经皮心室修复
4. Left ventricular assist devices for destination therapy in end-stage heart failure: the REMATCH trial [C] . Farrar, D.J. . 2002

机译：终末期心力衰竭用于目的地治疗的左心室辅助设备：REMATCH试验
5. Factors associated with adherence in heart failure. A secondary analysis of a large clinical trial: Candesartan in Heart failure -Assessment of Reduction in Mortality and Morbidity (CHARM) [D] . Granger, Bradi B. 2004

机译：与心力衰竭依从性相关的因素。大型临床试验的次要分析：坎地沙坦治疗心力衰竭-死亡率和发病率降低的评估（CHARM）
6. Percutaneous Ventricular Restoration Therapy Using the Parachute Device in Chinese Patients with Ischemic Heart Failure: Three-Month Primary End-point Results of PARACHUTE China Study [O] . Yue-Jin Yang, Yong Huo, Ya-Wei Xu, 2016

机译：使用降落伞装置进行的中国缺血性心力衰竭患者的经皮心室修复治疗：PARACHUTE China研究的三个月主要终点结果
7. Percutaneous Ventricular Restoration Therapy Using the Parachute Device in Chinese Patients with Ischemic Heart Failure: Three-Month Primary End-point Results of PARACHUTE China Study [O] . Yue-Jin Yang, Yong Huo, Ya-Wei Xu, 2016

机译：中国缺血性心力衰竭患者使用降落伞装置进行经皮心室修复治疗：paRaCHUTE中国研究的3个月主要终点结果

CardioKinetix completes enrollment in Chinese trial of first-of-its-kind parachute device for treatment of heart failure

摘要

著录项

相似文献

相关主题

期刊订阅